ARCHIVES

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Conversation With The Cancer Letter: PanCAN CEO Denies Bill Would Undermine NCI’s Role in Directing and Funding Research

August 3, 2012

In Brief: BRI Gets New FCRF Basic Research Contract; Senate Subcommittee Less Generous Than House

October 2, 1987

NCI Programs: NCI To Study Colorectal Cancer Screening Practices

September 17, 1999

OMB Backs Down, Releases New Construction Funds After Ruling They Are “Alteration, Renovation”

December 13, 1974

NCI apologize For Mismanagement Of NSABP, Says Fisher Resisted Criticism

April 22, 1994

NCI’s Douglas Lowy and John Schiller Honored with National Medal

December 12, 2014